#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain injury Congenital hypotransferrinaemia Chronic cutaneous lupus erythematosus Rhabdomyosarcoma Glomerulonephritis Cardiomyopathy Mitochondrial DNA depletion Anaplastic large cell lymphoma T- and null-cell types Central nervous system lymphoma Hepatitis B Non-renal cell carcinoma of kidney Acromegaly Basal cell naevus syndrome Bone marrow disorder Inflammatory myofibroblastic tumour More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma Crigler-Najjar syndrome – Life with Disease Glomerulonephritis membranoproliferative – Trials in Disease Indolent systemic mastocytosis – Trials in Disease Rhabdoid tumour Pelizaeus-Merzbacher disease – Basic Information Adrenocortical carcinoma – Trials in Disease Hairy cell leukaemia – Treatment Hereditary optic atrophy – Basic Information Antithrombin III deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Almagate Canis Familiaris (553) Zopiclone Charcoal, Activated Azd2693 Sodium Bp1.7881A Aflibercept Human Serum Albumin 5% Eculizumab Copper (64Cu) Chloride BENZYLPENICILLIN PROCAINE Meldonium D-Camphor Bgb-A445 CICLOPIROX Neflamapimod ULIXERTINIB Soya Oil, Purified Ab-729 Nelarabine More therapies…

    Learn about Your Condition

    Gastrointestinal carcinoma Hyperthyroidism Phaeochromocytoma Bronchiolitis Diabetic ketoacidosis Senile dementia Primary adrenal insufficiency Combined immunodeficiency Latent tuberculosis Synovial sarcoma metastatic Neurofibromatosis Retinal neovascularisation Pyelonephritis Critical illness Psychotic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Extending Dosing Intervals of Mepolizumab and Dupilumab for Patients with Severe Asthma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dupilumab
    • Mepolizumab
    The Netherlands

  • Study on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Treprostinil
    Austria Czechia France Germany Hungary Italy +6

  • Study on the Effect of Furosemide and Amiloride Hydrochloride on Kidney Stone Fragments After Laser Treatment in Patients Undergoing Flexible Ureteroscopy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    France

  • Study on Trametinib, Dexamethasone, Cyclophosphamide, and Cytarabine for Children with Relapsed or Refractory Blood Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor B-lymphoblastic lymphoma recurrent
    • Precursor B-lymphoblastic lymphoma refractory
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    Investigated Drugs:
    • Trametinib
    Austria Belgium Denmark Finland France Germany +5

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Irinotecan Hydrochloride Trihydrate
    France Italy

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Treosulfan
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Belgium France
Previous Page
1 … 535 536 537 538 539 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!